News archive search
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
Active search
Search results
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Becton Dickinson (BDX) is back in focus after announcing a collaboration with EMS to support the launch of a semaglutide therapy in Brazil. The …
Sharemaestro market context Price below Trend Line 52 weeks -20.7% · Next-week setup negative 16.7%Collaboration pairs leadership in pharmaceuticals and advanced drug delivery technology to support a consistent, reliable treatment experience for metabolic disease patients. FRANKLIN LAKES, N.J. and SÃO PAULO, July 29, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology …
Sharemaestro market context Price below Trend Line 52 weeks -20.7% · Next-week setup negative 16.7%BD (Becton, Dickinson and Company) and EMS, a leading Brazilian pharmaceutical company, have collaborated to launch an EMS semaglutide therapy in Brazil using the BD Vystra™ Injection Pen platform. This partnership aims to enhance access to GLP-1 treatments for chronic metabolic diseases like obesity …
This article provides a detailed profile of the BDX.GJ bond issued by Becton, Dickinson & Co. It outlines key metrics such as the issuer, issue date, maturity date, outstanding amount, face value, minimum denomination, and coupon rate. The bond's profile is focused on the …
This article provides an analysis of Rhinebeck Bancorp Inc (RBKB)'s financial health, noting a current financial score of 6.97 and a weak financial status within the Banking Services industry. Despite high operating efficiency, the company experienced year-over-year decreases in both revenue and net profit. …
Becton, Dickinson & Co. (BDX) has an estimated 69,784 total employees worldwide as of March 2026, marking a 5.3% decline from 2023. Despite this reduction in headcount, the company is actively hiring, with 3,619 active job postings in 2026, a 33.8% increase from the …
Rhinebeck Bank (NASDAQ: RBKB) has appointed Travis Podolec as Senior Vice President, Commercial Lender for its Orange County team, effective July 28, 2026. Podolec brings over 20 years of commercial lending experience in the Hudson Valley and Greater New York area, and will focus …
Rhinebeck Bank, a subsidiary of Rhinebeck Bancorp, Inc. (NASDAQ:RBKB), has appointed Travis Podolec as Senior Vice President, Commercial Lender for its Orange County team. Podolec brings over 20 years of experience in the Hudson Valley market and will focus on expanding the bank's commercial …
BD (Becton, Dickinson and Company) has announced that its Board of Directors declared a quarterly dividend of $1.05 per common share. This dividend is payable on September 30, 2026, to shareholders of record as of September 9, 2026. The indicated annual dividend rate is …
Sharemaestro market context Price below Trend Line 52 weeks -20.7% · Next-week setup negative 16.7%Becton, Dickinson and Company (BDX) saw its stock surge 5.4% on Tuesday, July 28, 2026, closing at $167.58, as part of a broad rally that uplifted the entire medical device sector. This coordinated move, which also saw gains from Abbott Laboratories, Stryker, and Intuitive …
Director Nancy Koskey Patzwahl recently purchased 25,000 shares of Rhinebeck Bancorp (NASDAQ:RBKB) stock for $11.94 per share, totaling $298,500. This acquisition increased her stake by over 1,100% to 27,270 shares. Rhinebeck Bancorp's stock has seen a 1.3% increase to $12.46, nearing its 52-week high, …
Rhinebeck Bancorp's CEO, Matthew James Smith, bought 12,425 shares of RBKB stock for $12 each, totaling $149,100 and increasing his ownership by over 52% to 36,251 shares. Following the purchase, RBKB shares rose 1.3% to $12.46. The company recently reported Q2 EPS of $0.24 …
Becton, Dickinson (BDX) shares rose by 3.9% after UBS initiated coverage with a Buy rating and a $190 price target, citing a cleaner post-Waters transaction outlook. The positive sentiment is also fueled by recent profit guidance increases, aggressive share repurchases, and anticipation of its …
Michael Feld, Executive Vice President and Chief Revenue Officer at Becton Dickinson & Co. (NASDAQ:BDX), sold 75 shares of the company's common stock for a total of $11,784, priced at $157.13 per share. This transaction was conducted on July 27, 2026, under a Rule …
Becton Dickinson & Co's EVP and Chief Revenue Officer, Michael Feld, sold 75 shares of common stock on July 27, 2026, at $157.13 per share. This transaction was conducted under a Rule 10b5-1 trading plan established on February 7, 2025. After the sale, Feld …
Zacks Investment Research has initiated coverage of Rhinebeck Bancorp, Inc. (RBKB) with a "Neutral" recommendation. The report acknowledges the company's resilient performance, strong capital base, and commercial banking franchise expansion potential, which are expected to support long-term growth. However, it also highlights risks such …
The Portnoy Law Firm has announced a class action lawsuit on behalf of Embecta Corp. (NASDAQ: EMBC) investors who purchased securities between November 25, 2025, and May 4, 2026. The lawsuit alleges that Embecta made misleading statements regarding its fiscal guidance, particularly concerning weakness …
UBS has initiated coverage on Becton Dickinson & Co. (NYSE:BDX) with a buy rating and a price target of $190.00, citing the company's de-rated valuation and anticipated mid-single-digit long-term growth. The firm believes market concerns about slowing growth and inflation are overstated, highlighting BD's …
A securities fraud class action lawsuit has been filed against Embecta Corp. (EMBC) and its executives following a significant stock drop of over 57% on May 5, 2026. The lawsuit alleges that Embecta misled investors about the strength of its insulin pen needle product …
The Gross Law Firm is reminding investors of Embecta Corp. (NASDAQ: EMBC) about an upcoming securities class action deadline of August 17, 2026. The lawsuit alleges that Embecta Corp. issued misleading statements regarding its fiscal results, specifically its pen needle business, leading to a …
Bronstein, Gewirtz and Grossman, LLC has announced a class action lawsuit against Embecta Corp. (NASDAQ:EMBC) and its officers. The lawsuit alleges that Embecta made false and misleading statements regarding its business and prospects, specifically about its pen needle business, which led to a significant …
This article first appeared on GuruFocus. Consolidated Net Sales: Decreased 13.9% to MXN9.9 billion. Net Sales (Constant Currency): Decreased 5.8%. Gross Profit: Decreased 21.2% to MXN5 billion. Gross Margin: Decreased from 55.1% to 50.4%. Operating Income: Decreased 27.3% with a margin of 17.4%. EBITDA: …
Kaplan Fox & Kilsheimer LLP has initiated a class action lawsuit against Embecta Corp. (EMBC) on behalf of investors who purchased securities between November 25, 2025, and May 4, 2026, and suffered losses. The lawsuit stems from a significant drop in Embecta's stock price …
Robbins LLP announced a class action lawsuit against Embecta Corp. (NASDAQ: EMBC) on behalf of investors who purchased securities between November 25, 2025, and May 4, 2026. The lawsuit alleges that Embecta misled investors regarding its business prospects, specifically by reaffirming revenue guidance for …
A class-action lawsuit has been filed against Embecta Corp. (NASDAQ: EMBC) alleging that the company made false and misleading statements and/or failed to disclose critical information regarding segment weakness, particularly in the U.S. pen needle market, which disrupted its revenue guidance and Q2 2026 …
Levi & Korsinsky, LLP has filed a securities class action lawsuit against Embecta Corp. (NASDAQ: EMBC) on behalf of investors who purchased shares between November 25, 2025, and May 4, 2026. The lawsuit alleges that Embecta's management concealed deteriorating conditions in the U.S. pen …
Bleichmar Fonti & Auld LLP (BFA Law) is reminding Embecta Corp. (NASDAQ:EMBC) investors of an August 17 lead plaintiff deadline for a securities fraud class action lawsuit. This follows a 57% stock drop after Embecta allegedly made misleading statements about the strength of its …
Search by ticker symbol or company name and select a result to open its chart.